Return
- 1M
- 3M
- 6M
- 1Y
- 3Y
- 5Y
This Fund:
Sensex:
BankFD:
Showing Funds Performance since Sep 07, 2020
Fund Overview
Min. investment
SIP ₹100 & Lump. ₹5000
AUM (Fund size)
₹7,875 Cr
Lock In Period
N/A
Expense Ratio
1.83
Benchmark
BSE Healthcare Total Return
Exit Load
1% if redeemed or switched out on or before completion of 1 month from the date of allotment of units.Nil, thereafter.
Summary
Latest details for Nippon India Pharma Fund Growth include a ₹508.7531 NAV as of Feb 24,2026 and returns since inception of 88.98%. Minimum investments start at SIP ₹100. The Nippon India Pharma Fund Growth AUM is ₹7,875 Cr, with a lock-in of N/A years, expense ratio of 1.83%, and benchmark BSE Healthcare Total Return. Exit load is - 1% if redeemed or switched out on or before completion of 1 month from the date of allotment of units.Nil, thereafter.. In the growth review for 1M Month/Year, the fund recorded 4.92% returns, against a category average of 0.80% and a category best of 6.18%.
Calculate Returns
You would have got
Your Investment Amount
- 1
- 2
- 3
- 4
- 5
Growth Review
| Duration | Fund Return(%) | Category Average(%) | Category Best(%) |
|---|---|---|---|
| 1M | 4.92 | 0.80 | 6.18 |
| 6M | -2.28 | 2.84 | 8.52 |
| 1Y | 9.79 | 6.98 | 12.79 |
| 3Y | 23.63 | 17.32 | 110.50 |
Portfolio Analysis
- Equity: 98.96%
- Debt: 1.04%
- Others
As on: 2026-01-31
View allocation % by
About Fund
Nippon India Pharma Fund Growth managed by Nippon India Mutual Fund,is a Healthcare & Pharmascheme with Assets Under Management of ₹7,875 Crore. The fund benchmarks its performance against the BSE Healthcare Total Return while maintaining an expense ratio of 1.83. Under the expert guidance of Sailesh Raj Bhan ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.
Peer Comparison
| Fund Name | Ratings | AUM | Expense Ratio |
|---|---|---|---|
| This FundTata India Pharma & HealthCare Fund Growth | 3 | 1239.57 CR | 2.14 |
| This FundAditya Birla Sun Life Pharma & Healthcare Fund Growth | 3 | 812.03 CR | 2.3 |
| This FundNippon India Pharma Fund Growth | 4 | 7875.4 CR | 1.83 |
| This FundSBI Healthcare Opportunities Fund Growth | 5 | 3822.73 CR | 1.94 |
| This FundICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth | 5 | 6658.41 CR | 1.86 |
| Fund Name | 1Y | 3Y |
|---|---|---|
| This FundTata India Pharma & HealthCare Fund Growth | 8.8495 | 87.8114 |
| This FundAditya Birla Sun Life Pharma & Healthcare Fund Growth | 9.5711 | 88.246 |
| This FundNippon India Pharma Fund Growth | 9.7868 | 88.9835 |
| This FundSBI Healthcare Opportunities Fund Growth | 7.9174 | 96.8476 |
| This FundICICI Prudential Pharma Healthcare & Diagnostics (P.H.D) Fund Growth | 8.661 | 105.1641 |
FAQs
Nippon India Pharma Fund Growth's fund is managed by experienced SEBI-registered investment fund manager , who implements the fund's strategy through research-backed decisions while adhering to its stated objectives.
The expense ratio of Nippon India Pharma Fund Growth is 1.83. This expense ratio is calculated by dividing the fund's operating expenses by its net assets.
Nippon India Pharma Fund Growth’s fund performance is as follows:
- 1 Month : 4.92%
- 6 Months : -2.28%
- 1 Year : 9.79%
- 3 Years : 23.63%
You can invest in Nippon India Pharma Fund Growth through SIP with a minimum of ₹500 monthly or make a lump sum investment of a minimum ₹1,000. Additional purchase minimums vary by scheme.
The fund size (AUM) of Nippon India Pharma Fund Growth is ₹7,875 crore. It changes based on market performance, inflows, and outflows.
You can track your investment in Nippon India Pharma Fund Growth through our website, our Choice FinX mobile app, regular statements, and email updates. Our customer support team is available for queries.
Min Inv Amount: ₹500